Although there was no report regarding the relationship between MDM‐2 genetic polymorphisms and ND or functional outcome after IS, some studies have shown that MDM‐2 polymorphisms may be a risk factor for uterine fibroids and hepatocellular carcinoma (Dong et al., 2012; Salimi et al., 2015). Here, MDM2 is linked to uterine corpus leiomyoma.